Saumya Sutaria - Tenet Healthcare CEO

THC Stock  USD 139.77  11.32  7.49%   

CEO

Dr. Saumya Sutaria, M.D. is Chief Operating Officer of the company since January 6, 2019. In this role, he oversees all of Tenets acute care hospitals and hospitalaffiliated outpatient facilities and physician practices. He also leads other functions across the enterprise within Tenet, USPI and Conifer. Prior to joining the Company, Dr. Sutaria worked for McKinsey Company for 18 years, most recently as a Senior Partner providing advisory support for hospitals, healthcare systems, physicians groups, ambulatory care models, integrated delivery, and governmentled delivery, while also working with institutional investors in healthcare. He previously held an associate clinical faculty appointment at the University of California at San Francisco, where he also engaged in postgraduate training with a focus in internal medicine and cardiology since 2021.
Age 48
Tenure 3 years
Address 14201 Dallas Parkway, Dallas, TX, United States, 75254
Phone469 893 2200
Webhttps://www.tenethealth.com

Latest Insider Transactions

2024-08-14Disposed of 86227 shares @ 154.41View
Sutaria received his bachelor’s degree in molecular and cellular biology and his bachelor’s degree in economics, both from the University of California, Berkeley, as well as his M.D. from the University of California, San Diego.

Tenet Healthcare Management Efficiency

The company has Return on Asset of 0.0681 % which means that on every $100 spent on assets, it made $0.0681 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.549 %, implying that it generated $0.549 on every 100 dollars invested. Tenet Healthcare's management efficiency ratios could be used to measure how well Tenet Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.04. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 214.4 M, whereas Intangible Assets are forecasted to decline to about 1.3 B.
Tenet Healthcare has 16.21 B in debt with debt to equity (D/E) ratio of 3.3, meaning that the company heavily relies on borrowing funds for operations. Tenet Healthcare has a current ratio of 1.37, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Tenet to invest in growth at high rates of return.

Similar Executives

Found 1 records

CEO Age

Gail BoudreauxElevance Health
63
Tenet Healthcare Corporation operates as a diversified healthcare services company. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas. Tenet Healthcare operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 76836 people. Tenet Healthcare (THC) is traded on New York Stock Exchange in USA. It is located in 14201 Dallas Parkway, Dallas, TX, United States, 75254 and employs 78,810 people. Tenet Healthcare is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Tenet Healthcare Leadership Team

Elected by the shareholders, the Tenet Healthcare's board of directors comprises two types of representatives: Tenet Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tenet. The board's role is to monitor Tenet Healthcare's management team and ensure that shareholders' interests are well served. Tenet Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tenet Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Johnston, Chief USPI
Meghan FitzGerald, Independent Director
Bill Durham, Chief Network
Christopher Lynch, Independent Director
Cecil Haney, Independent Director
Nadja West, Independent Director
Liz Johnson, Chief Officer
Richard Fisher, Independent Director
Paola Arbour, Executive Vice President, Chief Information Officer
William III, Vice Relations
Howard Hacker, Executive Vice President, Chief Compliance Officer
Lloyd Austin, Independent Director
Richard Mark, Independent Director
J Kerrey, Lead Independent Director
Lisa Foo, Executive Vice President - Commercial Operations
Tammy Romo, Independent Director
Sun Park, Executive CFO
Saumya Sutaria, President, Chief Executive Officer, Chief Operating Officer, Director
Michael Maloney, Executive Development
James Bierman, Independent Director
Thomas Arnst, Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary
Daniel Cancelmi, Chief Financial Officer, Executive Vice President
Saumya MD, CEO and President
Sandra Karrmann, Chief Human Resource Officer, Executive Vice President
Audrey Andrews, Executive Vice President, General Counsel, Corporate Secretary
Ronald Rittenmeyer, Executive Chairman of the Board, Chief Executive Officer
Marie Quintana, Executive Vice President - Communications, Chief Marketing Officer
Jana Durfee, Senior Officer
Clint Hailey, Chief VP

Tenet Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tenet Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenet Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.306
Earnings Share
27.46
Revenue Per Share
209.441
Quarterly Revenue Growth
0.004
Return On Assets
0.0681
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenet Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.